Recent studies reveal the potential of RMP1-14, a specifically developed anti-mouse PD-1 reagent , for enhancing cancer treatment. Unlike current approaches, RMP1-14 exhibits superior interaction to https://www.targetmol.com/compound/anti_mouse_pd_1_antibody_rmp1_14